Use of HDAC inhibitors for treatment of cardiac rhythm disorders
US9884031B2 · kind B2 · utility
4Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2008 |
| Grant date | Feb 6, 2018 |
| Priority date | — |
| Expiry date | May 20, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of ameliorating or reducing the extent of cardiac arrhythmia disorders, by administering an inhibitor of histone deacetylase enzyme (HDAC).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.